Wells Fargo & Company Absci Corp Transaction History
Wells Fargo & Company
- $433 Billion
- Q4 2024
A detailed history of Wells Fargo & Company transactions in Absci Corp stock. As of the latest transaction made, Wells Fargo & Company holds 44,027 shares of ABSI stock, worth $218,373. This represents 0.0% of its overall portfolio holdings.
Number of Shares
44,027
Previous 30,979
42.12%
Holding current value
$218,373
Previous $118,000
2.54%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding ABSI
# of Institutions
138Shares Held
58.9MCall Options Held
180KPut Options Held
139K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl8.27MShares$41 Million0.19% of portfolio
-
Redmile Group, LLC San Francisco, CA8.25MShares$40.9 Million1.69% of portfolio
-
Fred Alger Management, LLC New York, NY6.51MShares$32.3 Million0.09% of portfolio
-
Black Rock Inc. New York, NY5.34MShares$26.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.77MShares$23.7 Million0.0% of portfolio
About Absci Corp
- Ticker ABSI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 92,843,504
- Market Cap $461M
- Description
- Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process....